Cue Biopharma Inc — Cash Flow (NASDAQ:CUE) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities -32.49 M-38.84 M-41.81 M39.96 M36.33 M 29.64 M Cash from investing activities 4.46 M9.11 M-24.61 M25 M32 K 6.94 M Cash from financing activities 58.61 M19.23 M53.66 M11.86 M10.24 M 15.87 M Free cash flow -33.09 M-39.75 M-41.98 M39.96 M36.26 M 29.46 M

Haberler

Cue Biopharma, hisse başına 0,28 dolar fiyatla 10 milyon dolarlık halka arz fiyatlandırdı

Cue Biopharma prices $10 million public offering at $0.28 per share

Cue Biopharma hisseleri halka arz duyurusu sonrası sert düştü

Cue Biopharma stock tumbles on public offering announcement

Cue Biopharma launches public offering of common stock and warrants

Cue Biopharma hisse senedi derecelendirmesi Citizens tarafından Piyasa Üstü Performans olarak yinelendi

Cue Biopharma stock rating reiterated at Market Outperform by Citizens

ImmunoScape, yeni kanser tedavisi için Cue Biopharma teknolojisini lisansladı

ImmunoScape licenses Cue Biopharma technology for novel cancer therapy

Cue Biopharma kazancı $0,02 ile beklentilere göre daha iyi, kâr ise beklentilere göre düşük

Cue Biopharma earnings beat by $0.02, revenue fell short of estimates

Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Lags Revenue Estimates